CARLI WILLARD: Open Payments
NPI 1972935211 · ENFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$35,863 in 180 payments from 22 companies in 2025. Trend: 2023 $4,812 · 2024 $28,806 · 2025 $35,863
Speaker / faculty: $29,167Food & beverage: $4,561Travel & lodging: $2,135
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 56 | $28,530 |
| ABBVIE INC. | 43 | $3,101 |
| Phathom Pharmaceuticals, Inc. | 9 | $2,182 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $502 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $355 |
| GENZYME CORPORATION | 3 | $214 |
| Lilly USA, LLC | 7 | $145 |
| Ardelyx, Inc. | 8 | $141 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Madrigal Pharmaceuticals | 4 | $113 |
Products named: TREMFYA, VOQUEZNA, LINZESS, CREON, STELARA, XIFAXAN, DUPIXENT, ENTYVIO.
Industry payments across CT — which companies pay providers there.
